-
ITI Pharma and Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 09/06/25 )
NAV
₹16.16
Last change
₹0.05 +0.0%
Fund Size (AUM)
219.06 Cr
Performance
-
Fund Details
ITI Pharma and Healthcare Fund Regular Growth
as of 09/06/25
AUM
219.06 Cr
Expense Ratio
2.35 %
Benchmark
Nifty Healthcare TR INR
ISIN
INF00XX01BL5
Fund Manager
Rohan Korde
Exit Load
0.5% if redeemed within 0-3 months
0% if redeemed after 3 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ITI Pharma and Healthcare Fund Regular Growth | 19.0% | 22.59% | - |
| Nifty Healthcare TR INR | 22.11% | 23.78% | 22.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
16.72% |
Divi's Laboratories Ltd |
6.23% |
Lupin Ltd |
5.83% |
Max Healthcare Institute Ltd Ordinary Shares |
5.34% |
Apollo Hospitals Enterprise Ltd |
5.31% |
Suven Pharmaceuticals Ltd |
5.2% |
Aurobindo Pharma Ltd |
4.24% |
Torrent Pharmaceuticals Ltd |
4.13% |
Mankind Pharma Ltd |
3.06% |
Alkem Laboratories Ltd |
2.91% |
Sector Allocation
Healthcare |
95.67% |
Basic Materials |
3.32% |
Industrials |
1.01% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.94% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.2% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
23.71% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
23.71% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
21.62% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
21.62% (5Y)
-
